- Home
- CZFS vs DMAC Comparison
CZFS vs DMAC Comparison
Compare CZFS & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZFS
- DMAC
- Stock Information
- Founded
- CZFS 1984
- DMAC 2000
- Country
- CZFS United States
- DMAC United States
- Employees
- CZFS N/A
- DMAC N/A
- Industry
- CZFS Major Banks
- DMAC Biotechnology: Pharmaceutical Preparations
- Sector
- CZFS Finance
- DMAC Health Care
- Exchange
- CZFS Nasdaq
- DMAC Nasdaq
- Market Cap
- CZFS 270.6M
- DMAC 274.1M
- IPO Year
- CZFS N/A
- DMAC N/A
- Fundamental
- Price
- CZFS $64.50
- DMAC $5.26
- Analyst Decision
- CZFS Strong Buy
- DMAC Strong Buy
- Analyst Count
- CZFS 1
- DMAC 3
- Target Price
- CZFS N/A
- DMAC $7.00
- AVG Volume (30 Days)
- CZFS 22.6K
- DMAC 116.4K
- Earning Date
- CZFS 01-28-2025
- DMAC 11-13-2024
- Dividend Yield
- CZFS 3.03%
- DMAC N/A
- EPS Growth
- CZFS 34.84
- DMAC N/A
- EPS
- CZFS 5.75
- DMAC N/A
- Revenue
- CZFS $98,201,000.00
- DMAC N/A
- Revenue This Year
- CZFS N/A
- DMAC N/A
- Revenue Next Year
- CZFS $9.21
- DMAC N/A
- P/E Ratio
- CZFS $11.24
- DMAC N/A
- Revenue Growth
- CZFS 19.13
- DMAC N/A
- 52 Week Low
- CZFS $38.52
- DMAC $2.14
- 52 Week High
- CZFS $75.40
- DMAC $6.41
- Technical
- Relative Strength Index (RSI)
- CZFS 42.07
- DMAC 51.81
- Support Level
- CZFS $62.53
- DMAC $4.53
- Resistance Level
- CZFS $67.63
- DMAC $6.41
- Average True Range (ATR)
- CZFS 2.57
- DMAC 0.48
- MACD
- CZFS -1.00
- DMAC -0.02
- Stochastic Oscillator
- CZFS 17.81
- DMAC 38.83
About CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management and retirement services.
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.